|
|
immune effector process
|
GO:0002252 |
321 |
0.593
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.581
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.571
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.559
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.537
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.491
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.374
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.361
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.328
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.300
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.279
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.257
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.256
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.255
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.236
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.233
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.215
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.215
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.213
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.211
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.210
|
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.205
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.198
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.196
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.186
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.183
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.177
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.176
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.172
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.172
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.170
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.162
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.160
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.158
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.141
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.136
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.132
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.130
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.125
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.121
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.119
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.118
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.113
|
|
|
|
positive regulation of type iii hypersensitivity
|
GO:0001805 |
3 |
0.113
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.113
|
|
|
|
type i hypersensitivity
|
GO:0016068 |
4 |
0.112
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.109
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.109
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.108
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.105
|
|
|
|
thrombin receptor signaling pathway
|
GO:0070493 |
2 |
0.101
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.101
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.101
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.100
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.099
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.099
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.099
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.099
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.099
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.099
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.097
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.097
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.096
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.096
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.094
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.094
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.093
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.087
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.086
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.086
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.085
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.084
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.082
|
|
|
|
mast cell mediated immunity
|
GO:0002448 |
20 |
0.082
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.081
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.081
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.081
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.081
|
|
|
|
g protein coupled purinergic nucleotide receptor signaling pathway
|
GO:0035589 |
1 |
0.080
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.080
|
|
|
|
detection of yeast
|
GO:0001879 |
2 |
0.080
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.079
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.076
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0045425 |
2 |
0.076
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.076
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.075
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.074
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.074
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.074
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.074
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.072
|
|
|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.072
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.071
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.070
|
|
|
|
regulation of type iii hypersensitivity
|
GO:0001803 |
3 |
0.070
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.069
|
|
|
|
fc epsilon receptor signaling pathway
|
GO:0038095 |
3 |
0.067
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.067
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.066
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.066
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.065
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.065
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.064
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.063
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.063
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.062
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.062
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.062
|
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.061
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.060
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.060
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.059
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.059
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.058
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.058
|
|
|
|
metanephric glomerular visceral epithelial cell differentiation
|
GO:0072248 |
2 |
0.057
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.057
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.056
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.056
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.056
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.056
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.055
|
|
|
|
positive regulation of dendritic cell dendrite assembly
|
GO:2000549 |
1 |
0.055
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.055
|
|
|
|
regulation of type i hypersensitivity
|
GO:0001810 |
4 |
0.054
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.054
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.053
|
|
|
|
positive regulation of dna biosynthetic process
|
GO:2000573 |
4 |
0.053
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.053
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.052
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.052
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.052
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.051
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.051
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.051
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.051
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.049
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.049
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.049
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.048
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.048
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.048
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.048
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.048
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.047
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.047
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.047
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.046
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.046
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.046
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.046
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.046
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.046
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.046
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.046
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.046
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.046
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.045
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.045
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.045
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.044
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.044
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.044
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.044
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.044
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.044
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.043
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.043
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.043
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.043
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.043
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.043
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.043
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.043
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.043
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.042
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.042
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.042
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.041
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
chemokine secretion
|
GO:0090195 |
5 |
0.041
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.041
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.040
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.040
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.040
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.040
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.039
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.039
|
|
|
|
cell surface pattern recognition receptor signaling pathway
|
GO:0002752 |
2 |
0.038
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.038
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.038
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.038
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.038
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.038
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.038
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.038
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.038
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.038
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.037
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.037
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.037
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.037
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.037
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.036
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.036
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.036
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.036
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.036
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.036
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.036
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.036
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.036
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.035
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.035
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.035
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.034
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.034
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.034
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.034
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.034
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.034
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.033
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.033
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.033
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.033
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.033
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.033
|
|
|
|
renal protein absorption
|
GO:0097017 |
1 |
0.033
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.033
|
|
|
|
lysosome localization
|
GO:0032418 |
20 |
0.032
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.032
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.032
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.032
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.032
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.032
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.032
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.032
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.031
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.031
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.031
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.031
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.031
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.031
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.031
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.030
|
|
|
|
positive regulation of t helper 2 cell cytokine production
|
GO:2000553 |
3 |
0.030
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.030
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.030
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.030
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.030
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.030
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.030
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.030
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.030
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.030
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.029
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.029
|
|
|
|
regulation of type ii hypersensitivity
|
GO:0002892 |
4 |
0.029
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.029
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.029
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.029
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.029
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.029
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.029
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.028
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.028
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.028
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.028
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.028
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.028
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.027
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.027
|
|
|
|
immune response inhibiting cell surface receptor signaling pathway
|
GO:0002767 |
3 |
0.027
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.027
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.027
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.027
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.027
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.027
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.027
|
|
|
|
positive regulation of type 2 immune response
|
GO:0002830 |
9 |
0.027
|
|
|
|
regulation of immunoglobulin production in mucosal tissue
|
GO:2000557 |
1 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.026
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.026
|
|
|
|
regulation of mast cell activation involved in immune response
|
GO:0033006 |
17 |
0.026
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.026
|
|
|
|
detection of oxidative stress
|
GO:0070994 |
1 |
0.025
|
|
|
|
positive regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000478 |
1 |
0.025
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.025
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.025
|
|
|
|
positive regulation of glomerulus development
|
GO:0090193 |
5 |
0.025
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.025
|
|
|
|
innate immune response activating cell surface receptor signaling pathway
|
GO:0002220 |
4 |
0.025
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.025
|
|
|
|
positive regulation of muscle adaptation
|
GO:0014744 |
2 |
0.025
|
|
|
|
basal protein localization
|
GO:0045175 |
1 |
0.025
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.024
|
|
|
|
positive regulation of g1 s transition of mitotic cell cycle
|
GO:1900087 |
9 |
0.024
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.024
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.024
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.024
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.024
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.024
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.024
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.024
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.024
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.024
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.023
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.023
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.023
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.023
|
|
|
|
negative regulation of type i hypersensitivity
|
GO:0001811 |
1 |
0.023
|
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.023
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.022
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.022
|
|
|
|
positive regulation of leukocyte degranulation
|
GO:0043302 |
10 |
0.022
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.022
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.022
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.022
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.022
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.022
|
|
|
|
type 2 immune response
|
GO:0042092 |
23 |
0.022
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.022
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.022
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.022
|
|
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.022
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.022
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.022
|
|
|
|
antibody dependent cellular cytotoxicity
|
GO:0001788 |
2 |
0.022
|
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.021
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.021
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.021
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.021
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.021
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.021
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.021
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.021
|
|
|
|
positive regulation of mast cell degranulation
|
GO:0043306 |
10 |
0.021
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.021
|
|
|
|
positive regulation of chemokine secretion
|
GO:0090197 |
4 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.021
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.021
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.021
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.021
|
|
|
|
negative regulation of metanephric mesenchymal cell migration
|
GO:2000590 |
1 |
0.021
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.020
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
10 |
0.020
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.020
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.020
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.020
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.020
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.020
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.020
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.020
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.019
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.019
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.019
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.019
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.019
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.019
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.019
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.019
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.019
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.019
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.019
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.019
|
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.019
|
|
|
|
regulation of renal albumin absorption
|
GO:2000532 |
1 |
0.019
|
|
|
|
regulation of t helper 1 cell cytokine production
|
GO:2000554 |
1 |
0.019
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.019
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.018
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.018
|
|
|
|
mast cell degranulation
|
GO:0043303 |
19 |
0.018
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
regulation of toll like receptor 9 signaling pathway
|
GO:0034163 |
3 |
0.018
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.018
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.018
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
histamine production involved in inflammatory response
|
GO:0002349 |
1 |
0.018
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.018
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.018
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.018
|
|
|
|
response to morphine
|
GO:0043278 |
9 |
0.018
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.017
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.017
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.017
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.017
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.017
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.017
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.017
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.017
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.017
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.017
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.017
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.017
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.017
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.017
|
|
|
|
phagocytosis recognition
|
GO:0006910 |
12 |
0.017
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.017
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.017
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.017
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.017
|
|
|
|
macrophage migration inhibitory factor signaling pathway
|
GO:0035691 |
2 |
0.017
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.017
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
|
positive regulation of type iia hypersensitivity
|
GO:0001798 |
4 |
0.017
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.017
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
37 |
0.017
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.016
|
|
|
|
hypersensitivity
|
GO:0002524 |
10 |
0.016
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.016
|
|
|
|
pyrimidine containing compound catabolic process
|
GO:0072529 |
3 |
0.016
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.016
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.016
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.016
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.016
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.016
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.016
|
|
|
|
positive regulation of macrophage chemotaxis
|
GO:0010759 |
5 |
0.016
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.016
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.016
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.016
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.016
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.016
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
|
|
oxygen metabolic process
|
GO:0072592 |
4 |
0.016
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.016
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.016
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.016
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.015
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.015
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.015
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.015
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.015
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
12 |
0.015
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.015
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.015
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
33 |
0.015
|
|
